All News

A survey of physicians revealed their thoughts on the prevalence and drivers of overtreatment.

As physicians treat patients with elevated low-density lipoprotein (LDL) cholesterol more aggressively with PCSK9 inhibitors and high-efficacy statins, a test that is more accurate at lower levels is essential.

There may be a connection between sleep troubles and attention-deficit/hyperactivity disorder (ADHD), according to an expert at the 30th European College of Neuropsychopharmacology Congress, which was held September 2-5 in Paris, France.

CheckMate-214 results presented at the European Society of Medical Oncology meeting show improved overall survival in patients with renal cell carcinoma treated with the nivolumab-ipilimumab combination, compared with sunitinib.

Dexcom's partnerships are giving people with diabetes technology that will be less invasive and use products that everyone else wears and uses: fitness trackers and smartphones.

Topical steroids typically prescribed are generic drugs, but the increase in the cost of generics means that out-of-pocket Medicare spending for topical steroids has risen. A new study found substituting the cheapest topical steroid could result in substantial savings.

In recent years, testing for the BRCA1/2 gene mutations has increased among women in both metropolitan and nonmetropolitan areas, helping to drastically reduce the gap in testing rates between the groups.

Children with or without attention deficit/hyperactivity disorder (ADHD), who demonstrate inattentiveness during childhood are associated with a worse academic performance up to 10 years later in life, according to research.

The use of oral contraceptives decreases the risk of rheumatoid arthritis (RA), according to a new study. However, the researchers did not find a link between breastfeeding and a reduced risk of ACPA-positive or ACPA-negative RA.

Hospitals with more nurses on staff and better nurse-patient communication tend to receive higher scores on patients’ satisfaction with pain management, according to new research.

Ohio Governor John Kasich and Colorado Governor John Hickenlooper sat together at an event co-hosted by the American Enterprise Institute and the Center for American Progress to discuss bipartisan consensus around health reform policies and their commitment to quality, not quantity, medicine.

The study's lead investigator said most of the focus after the World Trade Center attacks has been on mental health, but there were physical effects, too.

Oncologist- as well as patient-initiated conversations on the cost of cancer care led to conversations on cost-reducing strategies 38% of the time, according to a new study published in the Journal of Oncology Practice.

The "Day of Action" seeks to unite people with diabetes online and asks them to contact their representatives. Fixing the insulin pricing system in the United States will be difficult-even experts say it's very complex.

This week, the top managed care stories included more insurers rolling back participation in Affordable Care Act exchanges, while governors testify ways to stabilize the market; the FDA put 3 combination trials of nivolumab on hold; and a study finds very few visits to the emergency department are truly avoidable.

The rate of stroke deaths, after declining for decades, is now on an alarming uptick, according to the CDC. In 3 out of 4 states, decreases in stroke deaths have slowed or reversed over time.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

“Is the pen mightier than the scalpel?” A new study aims to answer that question by presenting research on a handheld pen-sized device that can rapidly determine cancer tissue borders during surgery.

Three separate applications are pending involving the SGLT2 inhibitor.

Trial results published in a recent article indicate that patients using tiotropium in the early stages of chronic obstructive pulmonary disease (COPD) had better lung function and a slower decline in function.

A bipartisan group of governors from 5 states testified to a Senate committee on ways to stabilize the individual health insurance market and bring down premiums for their residents.

Data presented during PAINWeek show that the rate of drug misuse among teenagers has dropped dramatically.

Bristol-Myers Squibb announced that the FDA has placed a clinical hold on 3 combination trials evaluating its programmed death-1 inhibitor nivolumab (Opdivo) in patients with relapsed/refractory multiple myeloma.

The addition of evolocumab to the standard background therapy for patients with atherosclerotic cardiovascular disease (ASCVD) would exceed the typically accepted range of cost-effectiveness, according to a new study.

The study uncovered differences by race and education level in lifetime obesity status.